Novozymes’ dividend policy is a payout ratio to shareholders of around 30% of net profit. The Board of Directors proposes that the Annual Shareholders’ Meeting approves a dividend of DKK 5.25 per share for the 2008 financial year. This will result in an expected total dividend payment of approximately DKK 325 million.
|Stock buy-back (million)||0||500||1,107||1,053||847|
|Net profit (million)||1,062||1,042||911||861||775|
|Number of shares outstanding,|
|Dividend per share||5.25*||5.0||4.5||4.0||3.5|
There are currently no stock buy-back programs running.
Novozymes’ decision to buy back stock is in general based on an assessment of the need for capital structure optimization, and whether excess capital can be invested in profitable growth opportunities. Stock buy-back may also be carried out to cover employee stock option obligations.
|Resolution adopted at the Annual Shareholders' Meeting||March 4, 2009|
|Last day of trading with right to dividend for 2008||March 4, 2009|
|First day of trading without right to dividend for 2008||March 5, 2009|
|Disbursement of dividend||March 10, 2009|